Risk/Benefit Tradeoff of Antithrombotic Therapy in Patients With Atrial Fibrillation Early and Late After an Acute Coronary Syndrome or Percutaneous Coronary Intervention:
This story is reported by American Heart Association Journals. Read what other outlets are saying below, then open the original report for full details.